Would it not be reasonable to assume that the first anti-aging therapies that are approved will go to the privleged? Then they would be commodified and provided to the less economically fortunate.
The first monoclonal antibody therapy hit markets decades ago. It still hasn’t percolated to even the middle class in countries like india.
If a drug or therapy truly does extend life span I can also see systems forming where the few want to keep it to themselves and away from the many. One way or another I can’t imagine this being the the top priority of anyone but the most vain (personal opinion) so I would not associate myself with such research is all.
If a drug or therapy truly does extend life span I can also see systems forming where the few want to keep it to themselves and away from the many. One way or another I can’t imagine this being the the top priority of anyone but the most vain (personal opinion) so I would not associate myself with such research is all.